A detailed history of Peak6 Investments LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Peak6 Investments LLC holds 18,001 shares of AZN stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,001
Previous 15,500 16.14%
Holding current value
$1.19 Million
Previous $1.21 Million 16.06%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $191,751 - $219,137
2,501 Added 16.14%
18,001 $1.4 Million
Q2 2024

Aug 13, 2024

BUY
$66.81 - $80.83 $567,684 - $686,812
8,497 Added 121.33%
15,500 $1.21 Million
Q1 2024

May 14, 2024

SELL
$61.03 - $69.57 $107,107 - $122,095
-1,755 Reduced 20.04%
7,003 $474,000
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $109,112 - $122,140
1,763 Added 25.2%
8,758 $589,000
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $453,625 - $501,541
6,995 New
6,995 $473,000
Q4 2022

Feb 10, 2023

SELL
$54.21 - $70.44 $3.63 Million - $4.72 Million
-66,970 Reduced 76.69%
20,354 $1.38 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $4.63 Million - $11.9 Million
87,324 New
87,324 $4.79 Million
Q1 2021

May 14, 2021

SELL
$47.16 - $54.44 $154,449 - $178,291
-3,275 Reduced 75.79%
1,046 $52,000
Q4 2020

Feb 12, 2021

SELL
$48.52 - $58.02 $1.19 Million - $1.42 Million
-24,535 Reduced 85.03%
4,321 $216,000
Q3 2020

Nov 13, 2020

BUY
$53.07 - $61.1 $70,954 - $81,690
1,337 Added 4.86%
28,856 $1.58 Million
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $1.05 Million - $1.34 Million
24,252 Added 742.33%
27,519 $1.46 Million
Q1 2020

May 14, 2020

BUY
$37.79 - $51.33 $123,459 - $167,695
3,267 New
3,267 $146,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.